Navigation Links
Kendle to Present at Robert W. Baird & Co. 2010 Health Care Conference
Date:9/8/2010

CINCINNATI, Sept. 8 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced the Company will participate in the upcoming Robert W. Baird & Co. 2010 Health Care Conference on Sept. 14, 2010 at the St. Regis New York in New York City.

Kendle's formal presentation will be given by Stephen Cutler, PhD, Senior Vice President and Chief Operating Officer and Keith Cheesman, Senior Vice President and Chief Financial Officer at 1:45 p.m. Eastern Time.

The presentation will be webcast and may be accessed at www.kendle.com in the "Investors Events & Presentations" section or at http://www.wsw.com/webcast/baird16/kndl.    

Slides will be available by 11 a.m. on the day of the presentation at www.kendle.com in the "Investors Events & Presentations" section. The webcast will be archived for 90 days following the live presentation.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide. As one of the world's largest global providers of Phase I-IV services, we offer experience spanning more than 100 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges.

Additional information and investor ki
'/>"/>

SOURCE Kendle International Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Kendle Appoints Jeffrey M. Zucker to Lead Global Patient Recruitment Efforts
2. Kendle Rated a Top CRO to Work with for Fourth Consecutive Year
3. Kendle Announces New Revolving Credit Facility
4. Kendle Announces Details Regarding Fourth Quarter and Full-Year 2009 Earnings Conference Call and Webcast
5. Kendle to Present at UBS Global Life Sciences Conference
6. Kendle to Present at Robert Baird 2009 Health Care Conference
7. Kendle Realigns C-Suite Leadership to Drive Increased Innovation, Productivity and Organizational Efficiency
8. Kendle Appoints Stephen Cutler, PhD Senior Vice President and Chief Operating Officer
9. Kendle Names Jarrod Pontius Chief Legal Officer
10. Kendle Expands Asia/Pacific Operations with Opening of Offices in Kuala Lumpur, Bangkok and Manila
11. Kendle Announces First Quarter 2009 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 2015 GEA Niro Soavi the leader ... homogenizer, the PandaPLUS 2000, which is ideal for new ... cell disruption . This compact laboratory homogenizer is ... liquid food, food additives and ingredients as well as ...
(Date:1/22/2015)... January 22, 2015 The laboratory information ... has witnessed a number of technological advancements due to ... requirements, growing need to integrate healthcare systems, and increasing ... challenges in system integration. Key players in the market ...
(Date:1/22/2015)... Pipette.com has added the Eppendorf ... portfolio of Eppendorf products. , The Eppendorf Centrifuge 5424/5424 ... 5424/5424 R and receive the following:, , ... or Eppendorf Reference 2 ,     3 Free ...
(Date:1/22/2015)... Controlled Substance Compliance Services (CSCS), a ... check the legal requirements around using controlled substances in ... , As their international operations expand and become increasingly ... built as a result of the first phase of ...
Breaking Biology Technology:GEA Niro Soavi Announces the PandaPLUS 2000 Homogenizer for Processing New Applications for Nanoemulsions and Cell Disruption 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 3Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 4Eppendorf Announces Promotional Bundle Which Includes: Eppendorf Centrifuge 5424, 3-Pack of Pipettes, and Tips - Available Now at Pipette.com 2Global Compliance Service for Controlled Substances to Expand to China 2
... Company Inc. (Nasdaq: NSTK ) announced today ... of Nastech. Dr. Brandt previously,held the title of ... Steven Quay will remain the Company,s Chairman and ... Gordon to the position of President of,Nastech as ...
... Technology,Development Group Corporation (Nasdaq: CTDC, "the Company" or ... and solutions focusing on,solar energy business in China, ... its strategic plan to focus the Company,s management ... energy., On December 18, 2007, the Company ...
... CLEVELAND, OH and VANCOUVER, Dec. 20 /PRNewswire-FirstCall/ - ... Inc. (NASDAQ: ANPI, TSX:,ANP), announced today that Athersys ... Administration (FDA) to begin a Phase I clinical ... of acute myocardial,infarction (AMI). The companies believe that ...
Cached Biology Technology:Nastech Announces Promotion of Gordon Brandt, M.D. to President 2Nastech Announces Promotion of Gordon Brandt, M.D. to President 3CTDC Announces the Disposal of Non-core Business 2Athersys and Angiotech announce authorization of Phase I intramyocardial stem cell U.S. clinical trial in acute myocardial infarction 2Athersys and Angiotech announce authorization of Phase I intramyocardial stem cell U.S. clinical trial in acute myocardial infarction 3Athersys and Angiotech announce authorization of Phase I intramyocardial stem cell U.S. clinical trial in acute myocardial infarction 4Athersys and Angiotech announce authorization of Phase I intramyocardial stem cell U.S. clinical trial in acute myocardial infarction 5Athersys and Angiotech announce authorization of Phase I intramyocardial stem cell U.S. clinical trial in acute myocardial infarction 6
(Date:1/22/2015)... Washington , January 20, 2015 Investorideas.com, ... tech stocks, releases video from the CES 2015 (Consumer Electronics ... Apollo Robbins . Apollo shows how easily ... smart wallet, a product of NXT-ID, Inc. (NASDAQ: ...
(Date:1/22/2015)... 2015 , Europe,s ... The European Patent Office to present a video retrospective of the ... be featured: Christofer Toumazou and Sophie Wilson   ... winners of the Award   Starting on 22 January ...
(Date:1/22/2015)... EyeLock, Inc. , a market leader of iris-based identity authentication ... to the new role of Senior Vice President of Mobile ... mobile platforms and wearable solutions for EyeLock,s technologies. Gerber brings ... semiconductor industry to his role at EyeLock, with expertise in ...
Breaking Biology News(10 mins):Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 3Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 2Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 3EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 2
... hydrogen, produce clean water and even create energy. ... also desalinate water, be used as flexible water filtration ... made into flexible solar cells and can also double ... bacteria-killing capabilities, it can also be used to develop ...
... oil extraction from soybean seeds. It is rich in protein, ... of the seeds and dependent on the line, and can ... The study looked at the role soybeans could ... soybean lines which were high in oleic acid and protein, ...
... ANN ARBORA common test used to determine mercury exposure ... of the toxic metal released from fillings, according to ... amalgam fillings slowly release mercury vapor into the mouth. ... question of whether this exposure presents a significant health ...
Cached Biology News:NTU scientist develops a multi-purpose wonder material to tackle enviromental challenges 2NTU scientist develops a multi-purpose wonder material to tackle enviromental challenges 3NTU scientist develops a multi-purpose wonder material to tackle enviromental challenges 4Measuring mercury: Common test may overestimate exposure from dental amalgam fillings 2Measuring mercury: Common test may overestimate exposure from dental amalgam fillings 3
... CDX2, a member of the caudal-related homeobox ... regulates both proliferation and differentiation in intestinal ... in triggering cells towards the phenotype of ... the maintenance of the phenotype. Clone CDX2-88 ...
Anti-GOSR2 Monoclonal AntibodyOther Sub-Family: not assigned-Other Applications: Immunocytochemistry, Immunoprecipitation, Western Blot...
V beta 5 Purified Anti-Human clone MH3-2, Isotype Mouse IgG 2a , kappa, 0.1 mg Consult technical datasheet for details....
Monoclonal Anti-Cystatin A tissue culture supernatant Solution containing 15 mM sodium azide human cystatin A ...
Biology Products: